Abstract:Multiple plant (fruits, vegetables) and spice (turmeric)-derived natural products, which have pleiotropic activities (anti-inflammatory, antioxidant, anti-apoptotic, neurogenic) are also neuroprotective in vitro against numerous chemical insults and promote behavioral recovery in vivo following embolic strokes. We have focused on 2 types of natural products: 1) curcumin-based compounds such as CNB-001 and 2) flavone-based compounds such as fisetin and baicalein. We have synthesized a new library of flavonoid molecules to improve their pharmacological characteristics and have selected candidates using a battery of vitro screening assays with stringent criteria: 1) HT22 hippocampal cell survival (in vitro ischemia model using 20μM iodoacetic acid); 2) primary mouse cortical neurons cell survival (in vitro excitotoxicity assay using 10μM glutamate); 3) HT22 hippocampal cell survival assay (oxytosis using 5 mM glutamate to induce non-NMDA mediated cell death due to the absence of NMDA receptors on HT22 cells). EC50 ≤ 100 nM and survival ≥80% in the IAA assay, ≥35% survival in the cortical neuron assay and EC 50 ≤ 300 nM and ≥50% survival in the oxytosis assay. All compounds were screened in triplicate using concentrations up to 10 μM. We chemically modified fisetin to improve its potency, increase blood brain barrier penetration (CLogP, an indicator of blood brain barrier penetration) and reduce tPSA (topographical polar surface area). We have developed a structure activity relationship (SAR) indicating that the absence of a hydroxyl group on the A ring of fisetin enhances its potency. Two compounds PM-001 and PM-004) are 6 fold more potent than fisetin. Altering a hydroxyl group at the 3-position of the B ring has no impact on activity. The addition of multiple hydrophobic groups to various positions on the A ring, such as the addition of methyl groups at the 6 and/or 7 position improved potency ∼10-100 fold over fisetin (e.g. compound PM-010) while the addition of a more hydrophobic naphthalene group (PM-002) and (PM-003) improved the potency ∼40 fold over fisetin and increased the ClogP and reduced the tPSA. SAR studies on the C ring suggested that hydrogen bond accepting groups such as a methoxy at the 4' position and a hydrogen bond donating group such as a hydroxyl at the 3' position further enhanced potency. For example compound CMS-064, CMS-069 and CMS-092 are some of the most potent compounds, with EC 50 s below 40 nM. These compounds also have CLogPs and tPSAs consistent with enhanced brain penetration. In conclusion, we have used a rational medicinal chemistry approach in combination with in vitro screening analysis to identify new flavonoid molecules to optimally promote neuroprotection. The molecules which will be discussed in detail are being further characterized and de-risked to treat stroke.

Abstract 2324: Translational Stroke Research: Identification Of A Novel Family Of Natural Product Derived Flavonoid-Based Polyphenols With Potent Pleiotropic Neuroprotective Activity.

Design, Synthesis, and Biological Evaluation of Novel Cinnamide Derivatives as Neuroprotective Agents for the Treatment of Cerebral Ischemia

The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress

Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents

Discovery of neuroprotective Agents: Potent, brain Penetrating, lipoic acid derivatives for the potential treatment of ischemic stroke by regulating oxidative stress and inflammation - a Preliminary study

The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review

An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways

Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke

Abstract 41: Synthesis And Pharmacological Validation Of Novel Neuroprotective Purinergic Receptor P2X4 Antagonists For The Treatment Of Ischemic Stroke

Novel Hybrids of 6-Amino-3-n-butylphthalide and Neuroprotective Groups against Ischemic Stroke

Design, Synthesis and Biological Evaluation of Novel (e)‐hydroxystyryl Aralkyl Sulfones As Neuroprotective Agents

Design, synthesis, and evaluation of n-butylphthalide and ligustrazine hybrids as potent neuroprotective agents for the treatment of ischemic stroke in vitro and in vivo

Design, synthesis and biological evaluation of N-salicyloyl tryptamine derivatives as multifunctional neuroprotectants for the treatment of ischemic stroke

Exploring the Constituents and Mechanisms of Polygonum multiflorum Thunb. in Mitigating Ischemic Stroke: A Network Pharmacology and Molecular Docking Study

Design, Synthesis and Pharmacological Evaluation of (E)-3,4-dihydroxy Styryl Sulfonamides Derivatives As Multifunctional Neuroprotective Agents Against Oxidative and Inflammatory Injury.

<i>In Vivo</i> Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets

Discovery of phenylcarbamoyl xanthone derivatives as potent neuroprotective agents for treating ischemic stroke

Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs

Synthetic phenylethanoid glycoside derivatives as potent neuroprotective agents.

Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders

Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents.